Malignant Mesothelioma: Current Conundrums over Risk Estimates and Whither Electron Microscopy for Diagnosis?

References

• Diseases of the Pleura, J Chrétien, A Hirsch. Masson, New York 1983
   Google Scholar
• The Pleura in Health and Disease, J Chretien, J Bignon, A Hirsch. Dekker, New York 1985
   Google Scholar
• Churg A. Neoplastic asbestos-induced diseases. Pathology of Occupational Lung Disease, A Churg, FHY Green. Igaku-Shoin, New York 1988; 279–325
   Google Scholar
• Hammar S P, Bolen J W. Pleural neoplasms. Pulmonary Pathology, DH Dail, SP Hammar. Springer, New York 1988; 973–1028
   Google Scholar
• Hammar S P. Pleural diseases. Pulmonary Pathology2d ed., DH Dail, SP Hammar. Springer, New York 1994; 1463–1579
   Google Scholar
• Henderson D W, Shilkin K B, Whitaker D. Introduction and historical aspects: with comments on mesothelioma registries. Malignant Mesothelioma, DW Henderson, KB Shilkin, SL Langlois, D Whitaker. Hemisphere, New York 1992; 1–22
   Google Scholar
• Henderson D W, Shilkin K B, Whitaker D, . The pathology of mesothelioma, including immunohistology and ultrastructure. Malignant Mesothelioma, DW Henderson, KB Shilkin, SL Langlois, D Whitaker, et al. Hemisphere, New York 1992; 69–139
   Google Scholar
• Henderson D W, Shilkin K B, Whitaker D, . Unusual histological types and anatomic sites of mesothelioma. Malignant Mesothelioma, DW Henderson, KB Shilkin, SL Langlois, D Whitaker, et al. Hemisphere, New York 1992; 140–166
   Google Scholar
• Henderson D W, Comin C E, Hammar S P, . Malignant mesothelioma of the pleura: current surgical pathology. Pathology of Lung Tumors, B Corrin, et al. Churchill Livingstone, New York 1997; 241–280
   Google Scholar
• Jaurand M-C, Bignon J. The Mesothelial Cell and Mesothelioma. Marcel Dekker, New York 1994
   Google Scholar
• Roggli V L, Sanfilippo F, Shelburne J D. Mesothelioma. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 109–164
   Google Scholar
• Roggli V L, Brody A R. Experimental models of asbestos-related diseases. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 257–297
   Google Scholar
• Battifora H, McCaughey WTE. Tumors of the Serosal Membranes: Atlas of Tumor Pathology, 3d series, fascicle 15. Armed Forces Institute of Pathology, Washington, DC 1995
   Google Scholar
• Mossman B T, Bignon J, Corn M, et al. Asbestos: scientific developments and implications for public policy. Science 1990; 247: 294–301
   PubMed Web of Science ®Google Scholar
• de Klerk N H, Armstrong B K. The epidemiology of asbestos and mesothelioma. Malignant Mesothelioma, DW Henderson, KB Shilkin, SL Langlois, D Whitaker. Hemisphere, New York 1992; 223–250
   Google Scholar
• Roggli V L. Mineral fiber content of lung tissue in patients with malignant mesothelioma. Malignant Mesothelioma, DW Henderson, KB Shilkin, SLP Langlois, D Whitaker. Hemisphere, New York 1992; 201–222
   Google Scholar
• de Klerk N. Environmental mesothelioma. The Mesothelial Cell and Mesothelioma: Lung Biology in Health and Disease, M-C Jaurand, J Bignon. Dekker, New York 1994; vol 78: 19–35
   Google Scholar
• Ferguson D A, Berry G, Jelihovsky T, et al. The Australian mesothelioma surveillance program 1979–1985. Med J Aust. 1987; 147: 166–172
   PubMed Web of Science ®Google Scholar
• Ferguson D. Malignant mesothelioma-the rising epidemic. Med J Aust. 1989; 150: 233–235
   Google Scholar
• de Klerk N H, Armstrong B K, Musk A W, Hobbs MST. Predictions of future cases of asbestos-related disease among former miners and millers of crocidolite in Western Australia. Med J Aust. 1989; 151: 616–620
   PubMed Web of Science ®Google Scholar
• Peto J, Hodgson J T, Matthews F E, Jones J R. Continuing increase in mesothelioma mortality in Britain. Lancet 1995; 345: 535–539
   PubMed Web of Science ®Google Scholar
• Musk A W, Bowman R V, Christmas T I, Robinson B W. Management of malignant mesothelioma. Malignant Mesothelioma, DW Henderson, KB Shilkin, SLP Langlois, D Whitaker. Hemisphere, New York 1992; 292–302
   Google Scholar
• Garlepp M J, Davidson J A, Leong C C, Robinson B W. Gene therapy of malignant mesothelioma. The Internet Book of Gene Therapy, RE Sobol, KJ Scanlon. Appleton & Lange, Norwalk, CT 1995; 257–267
   Google Scholar
• Garlepp M J, Leong C C. Biological and immunological aspects of malignant mesothelioma. Eur Respir J. 1995; 8: 643–650
   Google Scholar
• Upham J W, Garlepp M J, Robinson B W. Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax. 1995; 50: 887–893
   PubMed Web of Science ®Google Scholar
• Garrard HGI, Gustafson I A, Stovall M R. Medicolegal aspects of asbestos-related diseases: Defendant's attorney's perspective. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 365–381
   Google Scholar
• Gordon JRC. Medicolegal issues in mesothelioma and asbestos disease litigation. Malignant Mesothelioma, DW Henderson, KB Shilkin, SLP Langlois, D Whitaker. Hemisphere, New York 1992; 328–350
   Google Scholar
• Motley R L, Patrick CWJ. Medicolegal aspects of asbestos-related diseases: plaintiff's attorney's perspective. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 347–364
   Google Scholar
• Henderson D W, Roggli V L, Shilkin K B, . Is asbestosis an obligate precursor for asbestos-induced lung cancer? Fiber burden and the changing balance of evidence: a preliminary discussion document. Sourcebook on Asbestos Diseases, GA Peters, BJ Peters, et al. Michie, Charlottesville, VA 1995; vol 11: 97–170
   Google Scholar
• Henderson D W, de Klerk N H, Hammar S P, . Asbestos and lung cancer: Is it attributable to asbestosis, or to asbestos fiber burden?. Pathology of Lung Tumors, B Corrin, et al. Churchill Livingstone, New York 1997; 83–118
   Google Scholar
• de Klerk N H, Armstrong B K, Musk A W, Hobbs MST. Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia. Br J Ind Med. 1989; 46: 529–536
   PubMedGoogle Scholar
• Berry G. Prediction of mesothelioma, lung cancer, and asbestosis in former Wittenoom asbestos workers. Br J Ind Med. 1991; 48: 793–802
   PubMedGoogle Scholar
• Rogers A J. Prediction of mesothelioma, lung cancer and asbestosis in former Wittenoom asbestos workers (letter). Br J Ind Med. 1992; 49: 451–452
   PubMedGoogle Scholar
• de Klerk N H, Musk A W, Ambrosini G L, et al. Comparison of the effects of retinol and beta-carotene for cancer prevention in former crocidolite workers from Wittenoom. Western Australia 1997, Submitted for publication
   Google Scholar
• Talcott J A, Thurber W A, Kantor A F, et al. Asbestos-associated diseases in a cohort of cigarette-filter workers. N Engl J Med. 1989; 321: 1220–1223
   PubMed Web of Science ®Google Scholar
• Baris Y I, Simonato L, Saracci R, Winkelman R. The epidemic of respiratory cancer associated with erionite fibres in the Cappadocian region of Turkey. Geographical and Environmental Epidemiology: Methods for Small-Area Studies, P Elliott, J Cuzick, D English, R Stern. Oxford University Press, Oxford 1992; 310–322
   Google Scholar
• Risberg B, Nickels J, Wågermark J. Familial clustering of malignant mesothelioma. Cancer 1980; 45: 2422–2427
   PubMed Web of Science ®Google Scholar
• Lynch H T, Katz D, Markvicka S E. Familial mesothelioma: Review and family study. Cancer Genet Cytogenet. 1985; 15: 25–35
   PubMedGoogle Scholar
• Hammar S P, Bockus D, Remington F, et al. Familial mesothelioma: a report of two families. Hum Pathol. 1989; 20: 107–112
   PubMed Web of Science ®Google Scholar
• Dawson A, Gibbs A, Browne K, et al. Familial mesothelioma: details of 17 cases with histopathological findings and mineral analysis. Cancer 1992; 70: 1183–1187
   PubMed Web of Science ®Google Scholar
• Lynch H T, Anton-Culver H, Kurosaki T. Is there a genetic predisposition to malignant mesothelioma?. The Mesothelial Cell and Mesothelioma: Lung Biology in Health and Disease, M-C Jaurand, J Bignon. Dekker, New York 1994; vol 78: 47–69
   Google Scholar
• Vianna N J, Polan A K. Non-occupational exposure to asbestos and malignant mesothelioma in females. Lancet 1978; 1: 1061–1063
   PubMed Web of Science ®Google Scholar
• Heineman E F, Bernstein L, Stark A D, Spirtas R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer 1996; 77: 549–554
   Google Scholar
• Comin C E, Henderson D W, Bowden J., Unpublished observation
   Google Scholar
• Perera F P. Uncovering new clues to cancer risk. Sci Am. 1996; 274: 40–46
   Google Scholar
• Carbone M, Pass H I, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene. 1994; 9: 1781–1790
   PubMed Web of Science ®Google Scholar
• Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol. 1993; 142: 1524–1533
   PubMed Web of Science ®Google Scholar
• Cristaudo A, Vivaldi A, Sensales G, et al. Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21 and SV40. J Environ Pathol Toxicol Oncol. 1995; 14: 29–34
   PubMedGoogle Scholar
• Pepper C, Jasani B, Navabi H, et al. Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax. 1996; 51: 1074–1076
   PubMed Web of Science ®Google Scholar
• Strickler H D, Goedert J J, Fleming M, et al. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev. 1996; 5: 473–475
   PubMed Web of Science ®Google Scholar
• Leigh J, Corvalan C, Copland P. Malignant mesothelioma incidence in Australia 1982-1992. Proceedings of the International Congress on Applied Mineralogy 1993; 28–30
   Google Scholar
• Roggli V L, Pratt P C, Brody A R. Analysis of tissue mineral fiber content. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 299–345
   Google Scholar
• Kauffman S L, Stout A P. Mesothelioma in children. Cancer 1964; 17: 539–544
   PubMed Web of Science ®Google Scholar
• Grundy G W, Miller R W. Malignant mesothelioma in childhood. Report of 13 cases. Cancer 1972; 30: 1216–1218
   PubMed Web of Science ®Google Scholar
• Armstrong G R, Raafat F, Ingram L, Mann J R. Malignant peritoneal mesothelioma in childhood. Arch Pathol Lab Med. 1988; 112: 1159–1162
   PubMedGoogle Scholar
• Nishioka H, Furusho K, Yasunaga T, et al. Congenital malignant mesothelioma: a case report and electron-microscopic study. Eur J Pediatr. 1988; 147: 428–430
   PubMedGoogle Scholar
• Peterson J T, Greenberg S D, Buffler P A. Non-asbestos-related malignant mesothelioma: a review. Cancer 1984; 54: 951–960
   PubMed Web of Science ®Google Scholar
• Antman K H, Ruxer R L, Aisner J, Vawter G. Mesothelioma following Wilms' tumor in childhood. Cancer 1984; 54: 367–369
   Google Scholar
• Anderson K A, Hurley W C, Hurley B T, Ohrt D W. Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer 1985; 56: 273–276
   Google Scholar
• Austin M B, Fechner R E, Roggli V L. Pleural malignant mesothelioma following Wilms' tumor. Am J Clin Pathol. 1986; 86: 227–230
   Google Scholar
• Andersson M, Wallin H, Jönsson M, et al. Lung carcinoma and mesothelioma in patients exposed to Thoro-trast: incidence, histology and p53 status. Int J Cancer. 1995; 63: 330–336
   PubMed Web of Science ®Google Scholar
• van Kaick G, Wesch H, Lührs H, . Epidemiological results and dosimetric calculations-an update of the German Thorotrast study. Health Effects of Internally Deposited Radionuclides: Emphasis on Radium and Thorium, G van Kaick, A Karaoglou, AM Kellerer, et al. World Scientific, Singapore 1995; 171–175
   Google Scholar
• Ishikawa Y, Mori T, Machinami R. Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels. J Cancer Res Clin Oncol. 1995; 121: 567–570
   Google Scholar
• Roggli V L, McGavran M H, Subach J, et al. Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases. Cancer 1982; 50: 2423–2432
   PubMed Web of Science ®Google Scholar
• Hillerdal G, Berg J. Malignant mesothelioma secondary to chronic inflammation and old scar: two new cases and review of the literature. Cancer 1985; 55: 1868–1972
   Google Scholar
• Hillerdal G. Non-malignant pleural disease. Thorax. 1981; 36: 669–675
   PubMed Web of Science ®Google Scholar
• Greenberg S D. Benign asbestos-related pleural diseases. Pathology of Asbestos-Associated Diseases, VL Roggli, SD Greenberg, PC Pratt. Little, Brown, Boston 1992; 165–187
   Google Scholar
• Lilienfeld D E. Asbestos-associated pleural mesothelioma in school teachers: a discussion of four cases. Ann NY Acad Sci. 1991; 643: 454–486
   Google Scholar
• Maltoni C, Pinto C, Mobiglia A. Mesotheliomas due to asbestos used in railroads in Italy. Ann NY Acad Sci. 1991; 643: 347–367
   Google Scholar
• Huncharek M. Changing risk groups for malignant mesothelioma. Cancer 1992; 69: 2704–2711
   PubMed Web of Science ®Google Scholar
• Landrigan P J, Kazemi H. The third wave of asbestos disease: exposure to asbestos in place. Ann NY Acad Sci. 1991; 643
   Google Scholar
• Ferguson D. Low-level asbestos-the priorities are wrong. Med J Aust. 1990; 152: 617–618
   Google Scholar
• Multiple authors. Asbestos cement products. Report by The Western Australian Advisory Committee on Hazardous Substances. Perth 1990
   Google Scholar
• World Health Organisation. Asbestos and other natural mineral fibres. Environmental Health Criteria 53. WHO, Geneva 1986
   Google Scholar
• Russell M, Gruber M. Risk assessment in environmental policy-making. Science 1987; 236: 286–290
   PubMed Web of Science ®Google Scholar
• Nicholson W J. Airborne mineral fibres in the non-occupational environment. IARC Sci Publ. 1989; 90: 239–261
   PubMedGoogle Scholar
• Warner F. Risk assessment. Report of a Royal Society group. Royal Society, London 1983
   Google Scholar
• Tossavainen A. Asbestos, asbestosis and cancer: exposure criteria. International Workshop on Asbestos, Asbestosis and Cancer. Criteria for Clinical Diagnosis, Helsinki January, 1997
   Google Scholar
• Steenland K, Loomis D, Shy C, Simonsen N. Review of occupational lung carcinogens. Am J Ind Med. 1996; 29: 474–490
   PubMed Web of Science ®Google Scholar
• Leigh J. Predicting future numbers of cases of asbestos-related disease in Australia. Asbestos-related Diseases: Setting the National Research Agenda 1996 to 2006. Sydney June, 1996
   Google Scholar
• Hammar S P, Bockus D E, Remington F L, Rohrbach K A. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas. Ul-trastruct Pathol. 1996; 20: 293–325
   PubMed Web of Science ®Google Scholar
• Naylor B. Pleural, peritoneal and pericardial fluids. Comprehensive Cytopathology, M Bibbo. WB Saunders, Philadelphia 1991; 541–614
   Google Scholar
• Churg A. Diseases of the pleura. Pathology of the Lung2d ed., WM Thurlbeck, AM Churg. Thieme Medical, New York 1995; 1080–1109
   Google Scholar
• Bedrossian CWM, Bonsib S, Moran C. Differential diagnosis between mesothelioma and adenocarcinoma: a multimodal approach based on ultrastructure and immunocytochemistry. Semin Diagn Pathol. 1992; 9: 124–140
   PubMed Web of Science ®Google Scholar
• Bedrossian CWM. Malignant mesothelioma and other pleural tumors. Pathology of Pulmonary Disease, MJ Saldana. Lippincott, Philadelphia 1994; 657–671
   Google Scholar
• Coleman M, Henderson D W, Mukherjee T M. The ultra-structural pathology of malignant pleural mesothelioma. Pathol Annu. 1989; 24(pt. 1)303–353
   PubMedGoogle Scholar
• Henderson D W, Leppard P J, Howard M J. The diagnostic fine structure of malignant mesothelioma. Bi-Regional Training Course on Electron Microscopy in Bio-Medical Research and Diagnosis of Human Diseases, TM Mukherjee. WHO, Adelaide 1991; 276–289
   Google Scholar
• Henderson D W. Transmission electron microscopy of malignant mesothelioma. MSA Bull. 1993; 23: 288–297
   Google Scholar
• Henderson D W, Attwood H D, Constance T J, et al. Lym-phohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultra-struct Pathol. 1988; 12: 367–384
   PubMed Web of Science ®Google Scholar
• Ordónˆez N G, Mackay B. The roles of immunohistochemistry and electron microscopy in distinguishing epithelial mesothelioma of the pleura from adenocarcinoma. Adv Anat Pathol. 1996; 3: 273–293
   Google Scholar
• Whitaker D, Shilkin K B. Diagnosis of pleural malignant mesothelioma during life-a practical approach. J Pathol. 1984; 143: 147–175
   PubMed Web of Science ®Google Scholar
• Whitaker D, Shilkin K B, Sterrett G F. Cytological appearances of malignant mesothelioma. Malignant Mesothelioma, DW Henderson, KB Shilkin, SL Langlois, D Whitaker. Hemisphere, New York 1992; 167–182
   Google Scholar
• van der Kwast T H, Delahaye M, Fleury J. Cytological diagnosis of malignant mesothelioma. The Mesothelial Cell and Mesothelioma: Lung Biology in Health and Disease, M-C Jaurand, J Bignon. Dekker, New York 1994; vol 78: 121–167
   Google Scholar
• Henderson D W, Whitaker D, Shilkin K B. The differential diagnosis of mesothelioma: a practical approach to diagnosis during life. Malignant Mesothelioma, D Henderson, K Shilkin, SL Langlois, D Whitaker. Hemisphere, New York 1992; 183–197
   Google Scholar
• Carr I, Toner P G. Rapid electron microscopy in oncology. J Clin Pathol. 1977; 30: 13–15
   PubMedGoogle Scholar
• Nesland J M, Millonig G, Wilson A, Johannessen J V. Rapid techniques in diagnostic electron microscopy. Ul-trastruct Pathol. 1982; 3: 295–300
   PubMed Web of Science ®Google Scholar
• Todd W J, Burgdorfer W. Rapid processing of biopsy specimens for examination by electron microscopy. Am J Clin Pathol. 1982; 77: 95–99
   Google Scholar